Create accountLogin

Recent searches

No recent searches

Search options

Only available when logged in.
shakedown.social is one of the many independent Mastodon servers you can use to participate in the fediverse.
A community for live music fans with roots in the jam scene. Shakedown Social is run by a team of volunteers (led by @clifff and @sethadam1) and funded by donations.

Administered by:

Server stats:

244
active users

shakedown.social: AboutStatusProfiles directoryPrivacy policy

Mastodon: AboutGet the appKeyboard shortcutsView source codev4.3.7

#joint

1 post1 participant0 posts today
Public
djw

Odd thing to ask on a Friday night, but worth a shot.

Anyone have experience with being young-ish going thru #joint replacement #surgery ?! Or surgery in general, this will be my first so gen input also appreciated.

Specifically curious abt things you wish you knew going in, questions to ask that I might not have considered, etc.

#medicine

(PS, I am 100% set on following standard of care here, zero interest in “alternative”, woo, chiro, etc. TY.)

Public
Chuck Darwin

Democrats are anticipating a large chunk of their caucus to sit out Israeli Prime Minister Benjamin #Netanyahu'saddress to a #joint #session Congress.
Why it matters:
It would represent a significant repudiation of the Israeli prime minister amid persistent Democratic objections to how he has conducted the war in Gaza.

Netanyahu's 2015 speech to Congress, which was a major snub of the Obama administration, was skippedby 58 Democratic lawmakers.
Many Democrats this year argued against inviting Netanyahu in the first place, accusing Republicans of attempting to divide their party with the speech.

Congressional Progressive Caucus Chair Pramila Jayapal (D-Wash.) told Axios the #boycott "will be large" and that there are "a lot of people who are extremely upset he is coming here."

Jayapal said she has spoken to several lawmakers who went to Netanyahu's 2015 speech but said they will not attend this time.
Rep. Jim McGovern (D-Mass.), the progressive ranking member of the House Rules Committee, told Axios he will not attend and said: "I wish it wasn't [happening]."
Several other progressives previously told Axios when the speech was first floated in March that they would sit it out.

Some Democrats who have tried to balance their support for Israel and their discomfort with how the war has been prosecuted are struggling with whether to attend, as Axios previously reported.
One House Democrat, speaking on the condition of anonymity, said a lot of members will "wait up until the very end to decide" whether they will attend, calling it a "very fluid, unpredictable situation."

The lawmaker said that whether there is a #ceasefire in Gaza by the time Netanyahu speaks will be the key factor, predicting anywhere from 50 to 100 Democrats will skip the speech if the war is still raging.
Another, senior House Democrat said it is "all being discussed" and that "a number [of Democrats] are going and #disrupting" the speech.

The other side: Rep. Mark Pocan (D-Wisc.), a senior Progressive Caucus member, told Axios he is "hoping to have a conversation about it."

axios.com/2024/06/04/democrats

Axios · Congress braces for "large" boycott, disruptions of Netanyahu speechBy Andrew Solender
Public
Chuck Darwin

#Wegovy®, #Zepbound®, and similar medications continue to gain attention for effectively treating #obesity, and now there is discussion—with research underway—about their potential for improving certain #surgical outcomes.

The brand-name medications mentioned above belong to a class called GLP-1 (glucagon-like peptide-1) agonists. #GLP-1s mimic the actions of the GLP-1 hormone, which is secreted in the gut and sends an “I’m full” signal to the brain after you eat.

GLP-1 medications aren’t new. @Ozempic® (generic name: #semaglutide) received approval from the U.S. Food and Drug Administration (FDA) to treat type 2 diabetes in 2017.

After its weight-loss effects were studied, semaglutide (at a higher dose and sold under the name Wegovy) was approved by the FDA as an anti-obesity medication in 2021, and others have since followed.

Most recently, the FDA approved Wegovy for patients with #cardiovascular #disease and obesity or overweight after a study showed that those taking the medication had a lower overall risk of major cardiac events, such as heart attack, stroke, or cardiovascular-related death.

Now, some Yale Medicine surgeons believe, based on their ongoing research, that taking anti-obesity medications before and sometimes after total #joint #replacement and #bariatric #surgery can be beneficial.

“These medications have been transformative, in terms of expanding the pool of people who can safely undergo joint replacement surgery,” says Daniel Wiznia, MD, a Yale Medicine orthopaedic surgeon and co-director of the Avascular Necrosis Program.

“These anti-obesity medications are game-changers; they are changing the way people practice medicine.”

Often, patients who need a total hip or knee replacement must delay surgery until they lose enough weight to meet specific body mass index ( #BMI ) standards.
This is important in protecting the patient’s health.

“Weight increases a patient’s risk of postoperative complications, including wound-healing problems, stroke, heart attack, blood clots, and infection,” he says.

However, having patients take a GLP-1 medication before surgery, as well as improving their diet, has allowed more patients to reach a safe preoperative BMI, Dr. Wiznia says.

yalemedicine.org/news/anti-obe

Public
KissAnne

I got a runner's knee #diagnosis #today. I have the strongest possible #artificial #joint in my left #knee. It was chosen because the posterior cruciate ligament was torn, and the knee would not have stabilized without this model. On the left side, the tendons are now irritatedand and tight. The reason is the stiffness of the model. This artificial joint does not flex at all laterally. It's a strong but "dummy knee" said the physiotherapist. I need to rest, take Burana and go to the massage.

A picture of an artificial joint The NexGen LCCK
ExploreLive feeds
About